TAK-715
TAK-715
ChemLeader
Catalog No:
CAS No.:
MDLNo:
Formula:
MW:
Size
Quantity
- +
Product Overview
Product Name TAK-715
CAS303162-79-0
FormulaC24H21N3OS
MW399.51
AppearanceWhite to off-white powder
Storage conditionStore in a dry and dark sealed container, short-term (weeks to months) storage at 0-4 ℃, long-term (months to years) storage at -20 ℃.
Security information
Product details

TAK-715 is an orally active and potent p38 MAPK inhibitor with IC50s of 7.1 nM, 200 nM for p38α and p38β, respectively. TAK-715 inhibits casein kinase I (CK1δ/ε) to regulate activation of Wnt/β-catenin signaling. TAK-715 shows good significant efficacy in a rat arthritis mode.


Related
Sorry, no related items
History
Libivirumab
BIO (GSK-3 Inhibitor IX | 6-bromoindirubin-3-oxime | 6-Bromoindirubin-3'-oxime | MLS 2052 | (2'Z,3'E)-6-Bromoindirubin-3'-oxime | 6-BIO | 6BIO
TAK-715
(±)-Stylopine hydrochloride | Tetrahydrocoptisine hydrochloride
Tosatoxumab
Amphotericin B | NSC 527017 | LNS-AmB
Streptozotocin (Synonyms: Streptozocin; Streptozocin; NSC-85998; U 9889; STZ)
10-Hydroxycamptothecin; (S)-10-Hydroxycamptothecin
Azaperone tartrate
Mirdametinib (PD0325901)